These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 20392492)

  • 21. Successful peripheral blood stem cell mobilization with granulocyte colony-stimulating factor in a patient with chronic myeloid leukemia achieving a complete cytogenetic remission with dasatinib after failing imatinib.
    Gabriel I; Chaidos A; Sorouri J; Dannie E; Davis J; Goldman J; Apperley J; Marin D
    Leukemia; 2008 Aug; 22(8):1618-9. PubMed ID: 18305564
    [No Abstract]   [Full Text] [Related]  

  • 22. Long-term remission in a patient with BCR/ABL-positive acute myeloid leukaemia on maintenance therapy with imatinib.
    Schalk E; Neum S; Kranz S; Scheinpflug K; Mohren M
    Leuk Res; 2009 Mar; 33(3):e6-7. PubMed ID: 18466968
    [No Abstract]   [Full Text] [Related]  

  • 23. Dasatinib in imatinib-resistant or -intolerant CML patients: data from the clinical practice of 6 hematological centers in the Czech Republic.
    Klamova H; Faber E; Zackova D; Markova M; Voglova J; Cmunt E; Novakova L; Machova-Polakova K; Moravcova J; Dvorakova D; Michalova K; Brezinova J; Oltova A; Jarosova M; Cetkovsky P; Indrak K; Mayer J
    Neoplasma; 2010; 57(4):355-9. PubMed ID: 20429627
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Philadelphia chromosome unmasked as a secondary genetic change in acute myeloid leukemia on imatinib treatment.
    Yip SF; Wan TS; Liu HS; Wong ML; So CC; Chan LC
    Leukemia; 2006 Nov; 20(11):2050-1. PubMed ID: 17024117
    [No Abstract]   [Full Text] [Related]  

  • 25. What's blasting off in CML?
    Oestreicher P
    ONS Connect; 2007; 22(8 Suppl):71-2. PubMed ID: 17824574
    [No Abstract]   [Full Text] [Related]  

  • 26. Dasatinib: from treatment of imatinib-resistant or -intolerant patients with chronic myeloid leukemia to treatment of patients with newly diagnosed chronic phase chronic myeloid leukemia.
    Abbott BL
    Clin Ther; 2012 Feb; 34(2):272-81. PubMed ID: 22285209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias.
    Talpaz M; Shah NP; Kantarjian H; Donato N; Nicoll J; Paquette R; Cortes J; O'Brien S; Nicaise C; Bleickardt E; Blackwood-Chirchir MA; Iyer V; Chen TT; Huang F; Decillis AP; Sawyers CL
    N Engl J Med; 2006 Jun; 354(24):2531-41. PubMed ID: 16775234
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sequential transient novel chromosomal translocations in a patient with chronic myelogenous leukemia in complete cytogenetic remission after therapy with imatinib mesylate.
    Papaioannou G; Athanasiadou A; Voutiadou G; Gaitatzi M; Batsis I; Touloumenidou T; Anagnostopoulos A
    Cancer Genet; 2011 Dec; 204(12):692-3. PubMed ID: 22285023
    [No Abstract]   [Full Text] [Related]  

  • 29. Response and resistance in 300 patients with BCR-ABL-positive leukemias treated with imatinib in a single center: a 4.5-year follow-up.
    Lahaye T; Riehm B; Berger U; Paschka P; Müller MC; Kreil S; Merx K; Schwindel U; Schoch C; Hehlmann R; Hochhaus A
    Cancer; 2005 Apr; 103(8):1659-69. PubMed ID: 15747376
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clonal evolution of abnormal Philadelphia chromosome-negative cells after imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia].
    Jiang Q; Chen SS; Jiang B; Jiang H; Lu Y; Qiu JY; Lu DP
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jan; 26(1):23-6. PubMed ID: 15946504
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Double Philadelphia-chromosome: a resistance factor on the imatinib mesylate therapy for chronic myeloid leukemia.
    Otero L; Ornellas MH; Dobbin J; de Souza Fernandez T
    Int J Lab Hematol; 2008 Aug; 30(4):346-8. PubMed ID: 18665834
    [No Abstract]   [Full Text] [Related]  

  • 32. Development of acute myeloid leukemia with NPM1 mutation, in Ph-negative clone, during treatment of CML with imatinib.
    Georgiou G; Efthymiou A; Vardounioti I; Boutsikas G; Angelopoulou MK; Vassilakopoulos TP; Kyrtsonis MC; Plata E; Tofas P; Bitsani A; Bartzi V; Pessach I; Dimou M; Panayiotidis P
    Leukemia; 2012 Apr; 26(4):824-6. PubMed ID: 21986839
    [No Abstract]   [Full Text] [Related]  

  • 33. Risk and prognosis of central nervous system leukemia in patients with Philadelphia chromosome-positive acute leukemias treated with imatinib mesylate.
    Pfeifer H; Wassmann B; Hofmann WK; Komor M; Scheuring U; Brück P; Binckebanck A; Schleyer E; Gökbuget N; Wolff T; Lübbert M; Leimer L; Gschaidmeier H; Hoelzer D; Ottmann OG
    Clin Cancer Res; 2003 Oct; 9(13):4674-81. PubMed ID: 14581336
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Haemorrhagic complications associated with reduced alpha2-plasmin inhibitor during imatinib use in a patient with Philadelphia chromosome-positive acute lymphoblastic leukaemia.
    Matsue K; Aoki T; Odawara J; Kimura S; Yamakura M; Takeuchi M
    Leuk Res; 2009 Jun; 33(6):867-9. PubMed ID: 18951628
    [No Abstract]   [Full Text] [Related]  

  • 35. Presence or the emergence of a F317L BCR-ABL mutation may be associated with resistance to dasatinib in Philadelphia chromosome-positive leukemia.
    Soverini S; Martinelli G; Colarossi S; Gnani A; Castagnetti F; Rosti G; Bosi C; Paolini S; Rondoni M; Piccaluga PP; Palandri F; Giannoulia P; Marzocchi G; Luatti S; Testoni N; Iacobucci I; Cilloni D; Saglio G; Baccarani M
    J Clin Oncol; 2006 Nov; 24(33):e51-2. PubMed ID: 17114651
    [No Abstract]   [Full Text] [Related]  

  • 36. Remission of Philadelphia chromosome-positive central nervous system leukemia after dasatinib therapy.
    Abdelhalim A; Barcos M; Block AW; Sait SN; Starostik P; Wetzler M; Wang ES
    Leuk Lymphoma; 2007 May; 48(5):1053-6. PubMed ID: 17487757
    [No Abstract]   [Full Text] [Related]  

  • 37. Isolated central nervous system lymphoid blast crisis in chronic myeloid leukaemia in major molecular remission.
    Barlow A; Robertson M; Doig A; Stewart W; Drummond MW
    Br J Haematol; 2008 Jul; 142(3):327. PubMed ID: 18492112
    [No Abstract]   [Full Text] [Related]  

  • 38. Detection of leukemia associated antigen-specific cytotoxic T cells in a patient with Philadelphia chromosome-positive leukemia during treatment with dasatinib.
    Matsushita M; Tonegawa K; Mori T; Kohashi S; Kato J; Matsuki E; Okamoto S; Hattori Y
    Leuk Lymphoma; 2014 Mar; 55(3):722-4. PubMed ID: 23746305
    [No Abstract]   [Full Text] [Related]  

  • 39. Excellent response to dasatinib of childhood Philadelphia positive intracranial acute lymphoblastic leukaemia tumours.
    Bhadri VA; Satharasinghe K; Sugo E; Barbaric D; Trahair TN
    Br J Haematol; 2011 Feb; 152(3):347-9. PubMed ID: 21155759
    [No Abstract]   [Full Text] [Related]  

  • 40. Very late relapse of Philadelphia chromosome positive acute megakaryoblastic leukemia.
    Patterson JM; Bolster L; Larratt L; Hamilton M; Brandwein J
    Leuk Lymphoma; 2015 Jul; 56(7):2203-5. PubMed ID: 25495169
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.